Talphera to Take part in Fireplace Chat on the 2024 Maxim Healthcare Digital Summit By Investing.com

SAN MATEO, Calif., Oct. 8, 2024 /PRNewswire/ — Talphera, Inc. (Nasdaq: TLPH), (“Talphera”), a specialty pharmaceutical firm targeted on the event and commercialization of modern therapies to be used in medically supervised settings, at the moment introduced that administration will take part in a hearth chat on the 2024 Maxim Healthcare Digital Summit and will probably be obtainable for 1×1 conferences with registered buyers. The summit is being held on October 15-17, 2024.

Occasion:   2024 Maxim Healthcare Digital Summit

Date:     October 16, 2024

Time:   3:00 PM ET / 12:00 Midday PT

Webcast hyperlink:  2024 Maxim Healthcare Digital Summit

About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical firm targeted on the event and commercialization of modern therapies to be used in medically supervised settings. Talphera’s lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is presently being studied underneath an investigational gadget exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has obtained Breakthrough Gadget Designation standing from the U.S. Meals and Drug Administration (FDA).

This launch is meant for buyers solely. For added details about Talphera, please go to www.talphera.com.